Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012

UPCOMING FEATURED EVENTS 1 2 Next 
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read
Molecular Diagnostics Europe13 Apr 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
Drug Discovery Chemistry21 Apr 2015 Read
ESCMID European Society of Clinical Microbiology and Infectious Diseases25 Apr 2015 Read


ALL UPCOMING EVENTS
1 2 3 Next 
Microscience29 Jun 2015 Read
Peptides8 Jul 2015 Read
AACC (American Association for Clinical Chemistry) Annual Meeting and Clinical Lab Expo26 Jul 2015 Read
International Conference on Transcriptomics27 Jul 2015 Read
Microscopy & Microanalysis2 Aug 2015 Read
WMIC 20152 Sep 2015 Read
World Drug Safety Congress Europe8 Sep 2015 Read
ASHG 20156 Oct 2015 Read
Neuroscience 201517 Oct 2015 Read
BioData World Congress21 Oct 2015 Read
AAPS 201525 Oct 2015 Read
Medica 201516 Nov 2015 Read
ASCB 201512 Dec 2015 Read